Insider · CIK 0001496182

HOMBACH ROBERT J.

Reports to the SEC for 8 companies · PARSIPPANY, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001496182

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-12	EMBCEmbecta Corp.P Purchase	Director	PPurchase	+45K sh	$4.97	+$224K	109,587.208
2026-06-22	SPTXSeaport Therapeutics, Inc.P Purchase	Director	PPurchase	+13K sh	$18.14	+$236K	13,000
2026-06-02	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+7,490 sh	—	—	49,360
2026-04-30	SPTXSeaport Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.3K sh	—	—	12,258
2026-03-06	HSICHENRY SCHEIN INCA Award	Director	AAward	+2,577 sh	—	—	5,421
2026-02-11	EMBCEmbecta Corp.A Award	Director	AAward	+22.8K sh	—	—	64,587.208
2025-05-20	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+6,650 sh	—	—	41,870
2025-03-04	HSICHENRY SCHEIN INCA Award	Director	AAward	+2,844 sh	—	—	2,844
2025-02-12	EMBCEmbecta Corp.A Award	Director	AAward	+13.8K sh	—	—	39,749.197
2024-05-21	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+4,720 sh	—	—	35,220
2024-02-07	EMBCEmbecta Corp.A Award	Director	AAward	+11.5K sh	—	—	24,903.902
2023-05-23	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+4,190 sh	—	—	30,500
2023-02-09	EMBCEmbecta Corp.A Award	Director	AAward	+6,979 sh	—	—	13,074.823
2022-05-26	Aptinyx Inc.Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2022-05-24	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+4,980 sh	—	—	26,310
2022-04-01	EMBCEmbecta Corp.A Award	Director	AAward	+6,024 sh	—	—	6,024
2021-11-12	Aptinyx Inc.P Purchase	Director	PPurchase	+74.6K sh	$2.40	+$179K	219,100
2021-11-12	Aptinyx Inc.P Purchase	Director	PPurchase	+74.6K sh	$2.40	+$179K	229,100
2021-11-11	Aptinyx Inc.P Purchase	Director	PPurchase	+5,400 sh	$2.40	+$13K	144,500
2021-11-11	Aptinyx Inc.P Purchase	Director	PPurchase	+5,400 sh	$2.40	+$13K	154,500
2021-07-02	KMXCARMAX INCA Award	Director	AAward	+1,308 sh	—	—	7,766
2021-05-27	Aptinyx Inc.Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2021-05-25	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+5,120 sh	—	—	21,330
2020-12-31	Aptinyx Inc.Stock Option (Right to Buy)A Award	Director	AAward	+5,620 sh	$2.22	+$12.5K	5,620
2020-09-30	Aptinyx Inc.Stock Option (Right to Buy)A Award	Director	AAward	+5,779 sh	$2.16	+$12.5K	5,779
2020-06-30	Aptinyx Inc.Stock Option (Right to Buy)A Award	Director	AAward	+4,669 sh	$2.68	+$12.5K	4,669
2020-06-26	KMXCARMAX INCA Award	Director	AAward	+2,021 sh	—	—	6,458
2020-05-27	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+4,300 sh	—	—	16,210
2020-05-20	Aptinyx Inc.Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2020-03-31	Aptinyx Inc.Stock Option (Right to Buy)A Award	Director	AAward	+9,218 sh	$1.36	+$12.5K	9,218
2020-01-10	Aptinyx Inc.P Purchase	Director	PPurchase	+50K sh	$3.00	+$150K	139,100
2019-12-31	Aptinyx Inc.Stock Option (Right to Buy)A Award	Director	AAward	+5,835 sh	$2.14	+$12.5K	5,835
2019-11-22	Aptinyx Inc.P Purchase	Director	PPurchase	+50K sh	$3.23	+$162K	89,100
2019-09-30	Aptinyx Inc.Stock Option (Right to Buy)A Award	Director	AAward	+6,002 sh	$2.08	+$12.5K	6,002
2019-06-28	KMXCARMAX INCA Award	Director	AAward	+2,020 sh	—	—	4,437
2019-06-28	Aptinyx Inc.Stock Option (Right to Buy)A Award	Director	AAward	+6,307 sh	$1.98	+$12.5K	6,307
2019-06-04	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+4,430 sh	—	—	11,910
2019-05-15	Aptinyx Inc.Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2019-03-29	Aptinyx Inc.Stock Option (Right to Buy)A Award	Director	AAward	+5,154 sh	$2.42	+$12.5K	5,154
2019-01-25	Aptinyx Inc.P Purchase	Director	PPurchase	+11.7K sh	$5.54	+$64.6K	49,100
2019-01-24	Aptinyx Inc.P Purchase	Director	PPurchase	+13.3K sh	$5.52	+$73.7K	37,445
2018-06-29	KMXCARMAX INCA Award	Director	AAward	+2,390 sh	—	—	2,417
2018-06-25	Aptinyx Inc.P Purchase	Director	PPurchase	+24.1K sh	$16.00	+$386K	24,100
2018-06-05	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+4,300 sh	—	—	7,480
2017-09-29	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+3,180 sh	—	—	3,180
2016-06-03	Baxalta IncD Disposition to Issuer	EVP. CFO and COO	DDisposition to Issuer	−209K sh	—	—	0
2016-06-03	Baxalta IncStock Option (Right to Buy)D Disposition to Issuer	EVP. CFO and COO	DDisposition to Issuer	−49.6K sh	—	—	0
2016-06-03	Baxalta IncStock Option (Right to Buy)D Disposition to Issuer	EVP. CFO and COO	DDisposition to Issuer	−95.2K sh	—	—	0
2016-06-03	Baxalta IncStock Option (Right to Buy)D Disposition to Issuer	EVP. CFO and COO	DDisposition to Issuer	−88.6K sh	—	—	0
2016-06-03	Baxalta IncStock Option (Right to Buy)D Disposition to Issuer	EVP. CFO and COO	DDisposition to Issuer	−103K sh	—	—	0

Recent filings

Accepted (ET)
Aug 134
HOMBACH ROBERT J.0000947871-26-000786
SEC(opens sec.gov)
Jun 244
HOMBACH ROBERT J.0001193125-26-280175
SEC(opens sec.gov)
Jun 44
HOMBACH ROBERT J.0001628280-26-040916
SEC(opens sec.gov)
May 44
HOMBACH ROBERT J.0001193125-26-204456
SEC(opens sec.gov)
Mar 94
HOMBACH ROBERT J.0001496182-26-000002
SEC(opens sec.gov)
Feb 134
HOMBACH ROBERT J.0000947871-26-000164
SEC(opens sec.gov)
May 224
HOMBACH ROBERT J.0001048477-25-000074
SEC(opens sec.gov)
Mar 64
HOMBACH ROBERT J.0000950170-25-034740
SEC(opens sec.gov)
Feb 144
HOMBACH ROBERT J.0000947871-25-000184
SEC(opens sec.gov)
May 234
HOMBACH ROBERT J.0001048477-24-000106
SEC(opens sec.gov)
Feb 94
HOMBACH ROBERT J.0000947871-24-000108
SEC(opens sec.gov)
May 244
HOMBACH ROBERT J.0001209191-23-031971
SEC(opens sec.gov)
Feb 104
HOMBACH ROBERT J.0001209191-23-008441
SEC(opens sec.gov)
May 314
HOMBACH ROBERT J.0001415889-22-005907
SEC(opens sec.gov)
May 264
HOMBACH ROBERT J.0001567619-22-011794
SEC(opens sec.gov)
Apr 54
HOMBACH ROBERT J.0001209191-22-023177
SEC(opens sec.gov)
Nov 164/A
HOMBACH ROBERT J.0001415889-21-005223
SEC(opens sec.gov)
Nov 154
HOMBACH ROBERT J.0001415889-21-005202
SEC(opens sec.gov)

Companies

Address

300 KIMBALL DRIVE

PARSIPPANY, NJ, 07054